Report Detail

Pharma & Healthcare Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Report 2021

  • RnM3689597
  • |
  • 28 May, 2021
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Diagnostic Radiopharmaceuticals & Contrast Media market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals & Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Radiopharmaceuticals
Contrast Media

Segment by Application
Hospital
Clinic
Other

The Diagnostic Radiopharmaceuticals & Contrast Media market is analysed and market size information is provided by regions (countries). Segment by Application, the Diagnostic Radiopharmaceuticals & Contrast Media market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion


1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview

  • 1.1 Diagnostic Radiopharmaceuticals & Contrast Media Product Scope
  • 1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
    • 1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Radiopharmaceuticals
    • 1.2.3 Contrast Media
  • 1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
    • 1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Trends (2016-2027)

2 Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Forecasts by Region

  • 2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2016-2021)
  • 2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)
    • 2.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)
    • 2.4.3 China Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)
    • 2.4.4 Japan Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)
    • 2.4.6 India Diagnostic Radiopharmaceuticals & Contrast Media Estimates and Projections (2016-2027)

3 Global Diagnostic Radiopharmaceuticals & Contrast Media Competition Landscape by Players

  • 3.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Sales (2016-2021)
  • 3.2 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Players by Revenue (2016-2021)
  • 3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2020)
  • 3.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Company (2016-2021)
  • 3.5 Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type

  • 4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2016-2021)
  • 4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Type (2022-2027)

5 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application

  • 5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2016-2021)
  • 5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Application (2022-2027)

6 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 6.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 6.1.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 6.1.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 6.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 6.2.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 6.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 6.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application (2022-2027)

7 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 7.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 7.2.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 8.1 China Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 8.1.1 China Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 8.1.2 China Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 8.2 China Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 8.2.1 China Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 8.3 China Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 9.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 9.1.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 9.1.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 9.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 9.2.1 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 10.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 10.1.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 10.2.1 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures

  • 11.1 India Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company
    • 11.1.1 India Diagnostic Radiopharmaceuticals & Contrast Media Sales by Company (2016-2021)
    • 11.1.2 India Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Company (2016-2021)
  • 11.2 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type
    • 11.2.1 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Type (2022-2027)
  • 11.3 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application
    • 11.3.1 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Diagnostic Radiopharmaceuticals & Contrast Media Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Diagnostic Radiopharmaceuticals & Contrast Media Business

  • 12.1 Amag Pharmaceuticals
    • 12.1.1 Amag Pharmaceuticals Corporation Information
    • 12.1.2 Amag Pharmaceuticals Business Overview
    • 12.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.1.5 Amag Pharmaceuticals Recent Development
  • 12.2 Bayer Healthcare
    • 12.2.1 Bayer Healthcare Corporation Information
    • 12.2.2 Bayer Healthcare Business Overview
    • 12.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.2.5 Bayer Healthcare Recent Development
  • 12.3 Bracco Imaging
    • 12.3.1 Bracco Imaging Corporation Information
    • 12.3.2 Bracco Imaging Business Overview
    • 12.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.3.5 Bracco Imaging Recent Development
  • 12.4 Daiichi Sankyo
    • 12.4.1 Daiichi Sankyo Corporation Information
    • 12.4.2 Daiichi Sankyo Business Overview
    • 12.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.4.5 Daiichi Sankyo Recent Development
  • 12.5 GE Healthcare
    • 12.5.1 GE Healthcare Corporation Information
    • 12.5.2 GE Healthcare Business Overview
    • 12.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.5.5 GE Healthcare Recent Development
  • 12.6 Guerbet
    • 12.6.1 Guerbet Corporation Information
    • 12.6.2 Guerbet Business Overview
    • 12.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.6.5 Guerbet Recent Development
  • 12.7 Lantheus
    • 12.7.1 Lantheus Corporation Information
    • 12.7.2 Lantheus Business Overview
    • 12.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.7.5 Lantheus Recent Development
  • 12.8 Mallinckrodt
    • 12.8.1 Mallinckrodt Corporation Information
    • 12.8.2 Mallinckrodt Business Overview
    • 12.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.8.5 Mallinckrodt Recent Development
  • 12.9 Medtronic
    • 12.9.1 Medtronic Corporation Information
    • 12.9.2 Medtronic Business Overview
    • 12.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.9.5 Medtronic Recent Development
  • 12.10 Nordion
    • 12.10.1 Nordion Corporation Information
    • 12.10.2 Nordion Business Overview
    • 12.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Products Offered
    • 12.10.5 Nordion Recent Development

13 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Cost Analysis

  • 13.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
  • 13.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
  • 14.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers

15 Market Dynamics

  • 15.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
  • 15.2 Diagnostic Radiopharmaceuticals & Contrast Media Drivers
  • 15.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
  • 15.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Diagnostic Radiopharmaceuticals & Contrast Media. Industry analysis & Market Report on Diagnostic Radiopharmaceuticals & Contrast Media is a syndicated market report, published as Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Report 2021. It is complete Research Study and Industry Analysis of Diagnostic Radiopharmaceuticals & Contrast Media market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,188.00
    4,782.00
    6,376.00
    3,720.00
    5,580.00
    7,440.00
    611,520.00
    917,280.00
    1,223,040.00
    333,720.00
    500,580.00
    667,440.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report